Achaogen Announces New Employment Inducement Grants
SOUTH SAN FRANCISCO, Calif., July 06, 2016 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ:AKAO), a clinical-stage biopharmaceutical company developing novel antibacterials addressing multi-drug resistant (MDR) gram-negative infections, today announced that on …